Local intra-articular injection of sodium hyaluronate delays articular cartilage degeneration after traumatic osteoarthritis

doi:10.3969/j.issn.2095-4344.2015.33.010

Abstract

Abstract:

BACKGROUND: Sodium hyaluronate is an effective treatment for osteoarthritis, but the underlying mechanism remains unclear. There is evidence that abnormal expressions of matrix metalloproteinase (MMP)-1, -3 and -9 and tissue inhibitor of metalloproteinase (TIMP)-1 and -2 show great effects on osteoarthritis.

OBJECTIVE: To assess the influence of intra-articular injection of sodium hyaluronate on expressions of MMPs-1, 3, 9 and tissue inhibitor of TIMPs-1, 2 in the rabbit cartilage after osteoarthritis.

METHODS: Twenty-four mature New Zealand white rabbits were divided into normal control, model, and sodium hyaluronate groups. The model and sodium hyaluronate groups underwent unilateral anterior cruciate ligament transection, and rabbits in the sodium hyaluronate group received 0.3 mL of 1% sodium hyaluronate via intra-articular injection at 4 weeks after modeling, once a week for 5 weeks. At 11 weeks following surgery, the rabbits were killed and the cartilage was harvested to extract total RNA. mRNA expressions of MMPs-1, 3, 9 and TIMPs-1, 2 in the cartilage were analyzed using real-time PCR for each group.

RESULTS AND CONCLUSION: Compared with the model group, the range and extent of cartilage damage was reduced in the sodium hyaluronate group (P < 0.01), and Mankin scores were noticeably decreased (P < 0.05). In the cartilage, mRNA expressions of MMPs-1, 3, 9 were enhanced and mRNA expressions of TIMPs-1, 2 were down-regulated in the model group. However, the mRNA expression levels of MMPs-1, 3, 9 and TIMPs-1, 2 in the articular cartilage were not obviously changed in the sodium hyaluronate group. These results suggest that MMPs-1, 3, 9 and TIMPs-1, 2 are involved in the progression of osteoarthritis and the therapeutic mechanism of sodium hyaluronate is not realized through the down-regulation of their expressions during development of osteoarthritis. Sodium hyaluronate for treatment of osteoarthritis is a complex process and the underlying mechanisms require further investigation.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Tissue Engineering, Osteoarthritis, Cartilage, Articular, Matrix Metalloproteinases

CLC Number:

R318

Zhou Jian-lin, Deng Shuang, Fang Hong-song, Peng Hao, Qiu Bo. Local intra-articular injection of sodium hyaluronate delays articular cartilage degeneration after traumatic osteoarthritis [J]. Chinese Journal of Tissue Engineering Research, 2015, 19(33): 5295-5300.

Figures/Tables 2

References

[1] Pelletier JP, Mineau F, Faure MP, et al. Imbalance between the mechanisms of activation and inhibition of metalloproteinases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990;33(10):1466-1476.
[2] Martel-Pelletier J, McCollum R, Fujimoto N, et al. Excess of metalloproteinases over tissue inhibitor metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest. 1994;70(6):807-815.
[3] Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84(2):678-685.
[4] Bluteau G, Gouttenoire J, Conrozier T, et al. Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section. Biorheology. 2002;39(1-2):247-258.
[5] Sasaki A, Sasaki K, Konttinen YT, et al. Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med. 2004;204(2):99-107.
[6] Tobetto K, Nakai K, Akatsuka M, et al. Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res. 1993;29(3):181-190.
[7] Pelletier JP, Jovanovic D, Fernandes JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum. 1998;41(7):1275-1286.
[8] Mankin HJ, Dorfman H, Lippiello L, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971;53(3):523-537.
[9] Goldring MB. Anticytokine therapy for osteoarthritis. Exp Opin Biol Ther. 2001;1(5):817-829.
[10] Takahashi K, Goomer RS, Harwood F, et al. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1 beta (IL-1 beta), and tissue inhibitor of metalloproteinase-1(TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage. 1999;7(2):182-190.
[11] Malemud CJ, Goldberg VM. Future directions for research and treatment of osteoarthritis. Front Biosci. 1999;4: D762-D771.
[12] Huebner JL, Otterness IG, Freund EM, et al. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum. 1998;41(5):877-890.
[13] Sun S, Bay-Jensen AC, Karsdal MA, et al. The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases. BMC Musculoskelet Disord. 2014;15:93.
[14] Lu QY, Han QH, Li X, et al. Analysis of differentially expressed genes between rheumatoid arthritis and osteoarthritis based on the gene co-expression network. Mol Med Rep. 2014;10(1):119-124.
[15] Amiel D, Toyoguchi T, Kobayashi K, et al.Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model. Osteoarthritis Cartilage. 2003;11(9):636-643.
[16] Hammesfahr JF, Knopf AB, Stitik T. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee. Am J Orthop (Belle Mead NJ). 2003;32(6):277-283.
[17] Hulmes DJ, Marsden ME, Strachan RK, et al. Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Osteoarthritis Cartilage. 2004;12(3):232-238.
[18] Hochberg MC. Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin Arthritis Rheum. 2000;30(2 Suppl 1):2-10.
[19] Barbucci R, Lamponi S, Borzacchiello A, et al. Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials. 2002;23(23):4503-4513.